202 related articles for article (PubMed ID: 3105186)
1. Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.
Holeski CJ; Eaton DL; Monroe DH; Bellamy GM
Xenobiotica; 1987 Feb; 17(2):139-53. PubMed ID: 3105186
[TBL] [Abstract][Full Text] [Related]
2. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
3. Modification of aflatoxin B1 biotransformation in vitro and DNA binding in vivo by dietary broccoli in rats.
Ramsdell HS; Eaton DL
J Toxicol Environ Health; 1988; 25(3):269-84. PubMed ID: 3141626
[TBL] [Abstract][Full Text] [Related]
4. Effects of single-dose and repeated-dose pretreatment with 2(3)-tert-butyl-4-hydroxyanisole (BHA) on the hepatobiliary disposition and covalent binding to DNA of aflatoxin B1 in the rat.
Monroe DH; Holeski CJ; Eaton DL
Food Chem Toxicol; 1986 Dec; 24(12):1273-81. PubMed ID: 3100404
[TBL] [Abstract][Full Text] [Related]
5. Butylated hydroxytoluene chemoprevention of aflatoxicosis - effects on aflatoxin B(1) bioavailability, hepatic DNA adduct formation, and biliary excretion.
Guarisco JA; Hall JO; Coulombe RA
Food Chem Toxicol; 2008 Dec; 46(12):3727-31. PubMed ID: 18929618
[TBL] [Abstract][Full Text] [Related]
6. Effect of butylated hydroxyanisole pretreatment on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in isolated hepatocytes from rats.
Jhee EC; Ho LL; Tsuji K; Gopalan P; Lotlikar PD
Cancer Res; 1989 Mar; 49(6):1357-60. PubMed ID: 2493978
[TBL] [Abstract][Full Text] [Related]
7. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
8. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
10. Hepatic transport of sulphobromphthalein and sulphobromphthalein-glutathione conjugate in control and phenobarbital-pretreated rats.
Fischer E; Gregus Z; Gógl A
Acta Physiol Acad Sci Hung; 1978; 51(1-2):61-6. PubMed ID: 754472
[TBL] [Abstract][Full Text] [Related]
11. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
Jhee EC; Ho LL; Lotlikar PD
Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
Gurtoo HL; Dave CV
Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
[TBL] [Abstract][Full Text] [Related]
13. The effect of phenobarbital pretreatment on the metabolism, covalent binding, and cytotoxicity of aflatoxin B1 in primary cultures of rat hepatocytes.
Loury DJ; Hsieh DP; Byard JL
J Toxicol Environ Health; 1984; 13(1):145-59. PubMed ID: 6201621
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
[TBL] [Abstract][Full Text] [Related]
15. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
16. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
17. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
Davis RA; Kern F
Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.
Maftouh M; Meunier G; Dugue B; Monsarrat B; Meunier B; Paoletti C
Xenobiotica; 1983 May; 13(5):303-10. PubMed ID: 6636827
[TBL] [Abstract][Full Text] [Related]
19. The effect of modulation of glutathione levels on markers for aflatoxin B1-induced cell damage.
Farombi EO; Nwankwo JO; Emerole GO
Afr J Med Med Sci; 2005 Mar; 34(1):37-43. PubMed ID: 15971552
[TBL] [Abstract][Full Text] [Related]
20. Excretion of aflatoxin B1 as a glutathione conjugate.
Emerole GO
Eur J Drug Metab Pharmacokinet; 1981; 6(4):265-8. PubMed ID: 6800796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
